RE:RE:RE:RE:RE:RE:Would you look at that..If you are talking about that insider transaction, two things. First, those were not company's (our shares) but that of an insider. Second, they were shares (I imagine which could have been sold by the recipient after the receipt). Not shares sold on the market and then cash forwarded to the recipient.
One relevant question is what benefits the insider received and whether the timing was appropriate given that he reasonably should have known that the value of those shares would have been to some extent lower had the donation occured after the disclosure of the quarterly results. The whole question whether that transaction was done during what could have reasonably been a blackout period during which time no insider transactions should take place.
I do not recall exactly the last time that PG answered questions publicly. Because of that, I did not listen to the last conference call but it sounds like he didn't this time either The transcript that I saw seemed like the majority of the content was pretty well verbatim from the news release. So, thanks but no thanks, I can read. Through news releases, I understood very well that they deliberately sought to expand the 10,000 Biocloud unit monthly manufacturing capacity to 20,000 and even sought out and received government money to do so. He never wrote or said publicly why he did that, but I think an average person would have reasonably deduced that he had foresight into demand that was above 10,000 monthly....MONTHLY....units...even for one month. I am no expert but one could easily argue that his disclosure practices were inadequate, and those led to many people losing a lot of money. No such investors ever recovered money lost through such means unfortunately. The best that can happen to us in practice going forward is not to be getting information from him anymore IMO. Let someone else decide how that happens.